Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary NeuroMetrix Reports Compliance With NASDAQ Listing Requirements
NeuroMetrix Reports Compliance With NASDAQ Listing Requirements WALTHAM, Mass., Sep 19, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported that it has received a letter from The NASDAQ Stock Market LLC ("NASDAQ") indicating that it has regained compliance with the minimum bid
View HTML
Toggle Summary NeuroMetrix Reports Product Milestone
Initiates Commercial Shipments of NC-stat DPNCheck
View HTML
Toggle Summary NeuroMetrix to Present at Rodman & Renshaw Annual Global Investment Conference
NeuroMetrix to Present at Rodman & Renshaw Annual Global Investment Conference WALTHAM, Mass., Sep 07, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), a science-based health care company improving patient care through neurotechnology, today announced that Shai N.
View HTML
Toggle Summary NeuroMetrix Announces One-for-Six Reverse Stock Split
Shares of Common Stock Will Begin Trading on a Split-Adjusted Basis on September 2, 2011
View HTML
Toggle Summary NeuroMetrix to Present at Canaccord Genuity Growth Conference
NeuroMetrix to Present at Canaccord Genuity Growth Conference WALTHAM, Mass., Aug 02, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), a science-based health care company improving patient care through neurotechnology, today announced that Shai N.
View HTML
Toggle Summary NeuroMetrix Reports Q2 2011 Results
Commercial NC-stat(R) DPNCheck(TM) Activity to Start During Q3
View HTML
Toggle Summary NeuroMetrix, Inc. Announces Date for 2011 Second Quarter Financial Results Conference Call
NeuroMetrix, Inc. Announces Date for 2011 Second Quarter Financial Results Conference Call WALTHAM, Mass., Jul 21, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today said it plans to issue its 2011 second quarter financial results before the opening of the market on July 28, 2011.
View HTML
Toggle Summary NeuroMetrix Reports Successful Marketing Launch of NC-stat(R)|DPNCheck(TM) at the American Diabetes Association 71st Scientific Sessions
NeuroMetrix Reports Successful Marketing Launch of NC-stat(R)|DPNCheck(TM) at the American Diabetes Association 71st Scientific Sessions WALTHAM, Mass., Jul 06, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it met its planned marketing launch date for NC-stat ®
View HTML
Toggle Summary NeuroMetrix To Launch Product Targeted at Diabetes Market at the American Diabetes Association 71st Scientific Sessions
NeuroMetrix To Launch Product Targeted at Diabetes Market at the American Diabetes Association 71st Scientific Sessions WALTHAM, Mass., Jun 20, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it expects to meet its planned launch date for its latest product, NC-stat ®
View HTML
Toggle Summary Nipro Diagnostics and NeuroMetrix Announce Diabetes Focused Collaboration for the Retail Medical Clinic Market
Nipro Diagnostics and NeuroMetrix Announce Diabetes Focused Collaboration for the Retail Medical Clinic Market WALTHAM, Mass. & FT LAUDERDALE, Fla., Jun 15, 2011 (BUSINESS WIRE) -- Nipro Diagnostics, Inc. and NeuroMetrix, Inc. (Nasdaq: NURO) today announced their collaboration to evaluate
View HTML